News|Articles|May 3, 2013
Orally Disintegrating Tablets
Author(s)Cynthia A. Challener
Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
Application of Predictive Modeling in the Development of Amorphous Solid Dispersions
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
5